Vincent P. Laudone, MD | Authors


2105 S DAY ST


Bladder Cancer Treatment: Optimize, Don't Compromise

December 16, 2011

Patient selection based on a much more comprehensive biologic assessment of both host and tumor is likely the key to further advances in the treatment of all bladder cancer patients. Until such time, there can be no compromise in the careful application of the rigorous therapy required to optimize outcomes.